NantHealth

NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the introduction of biosimilars and identify opportunities for technology solutions to reduce the administrative burden. Topics include: • Lessons learned from biosimilars in oncology treatment • The significant impact biosimilars will have on treatment considerations for…